Tag: autoinjectors market share

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Autoinjectors Market from 2024 to 2033?

The autoinjectors market will increase from $3.06 billion in 2023 to $3.79 billion in 2024, at a CAGR of 23.6%. Growth is attributed to the rising prevalence of chronic diseases, an aging population, advancements in biotechnology and pharmaceuticals, greater patient preference for self-administration, and regulatory support.

The autoinjectors market is set to see robust growth, reaching $8.37 billion by 2028 at a CAGR of 21.9%. This growth is fueled by the expansion of therapeutic applications, rising healthcare costs, a stronger focus on patient-centered care, the rise of telemedicine, and growth in emerging markets. Key trends include personalized drug delivery, smart and connected autoinjectors, needle-free devices, biologic drug delivery, and enhanced safety features.

Claim Your Free Sample of the Global Autoinjectors Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp

What Key Factors Are Fueling the Growth of the Autoinjectors Market?

The growing prevalence of chronic diseases is fueling the autoinjectors market. Chronic conditions like diabetes and rheumatoid arthritis require regular doses of biologics, administered via autoinjectors. Research by Imperial College London in 2020 indicated chronic diseases are responsible for 41 million annual deaths globally, reinforcing the market’s growth.

What Are the Major Segments of the Autoinjectors Market?

1) By Type: Disposable Autoinjectors, Reusable Autoinjectors

2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies

3) By Route Of Administration: Subcutaneous, Intramuscular

4) By Distribution Channel: Online Retailer, Pharmacy

5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users

What New Trends Are Transforming the Autoinjectors Market?

Technological advancements are shaping the autoinjectors market, with companies focusing on developing new solutions to meet the demand for biologic delivery systems. In February 2021, Becton Dickinson developed the Intevia 2.25 mL autoinjector, designed with a thinner wall cannula and compatible with BD Neopak XtraFlow prefillable syringes. This patient-centric device enhances delivery efficiency with an 8-millimeter needle.

Order Now for Fast Delivery of Your Autoinjectors Market Report!

https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

Which Regions Are Driving Growth in the Autoinjectors Market?

North America was the largest region in the autoinjectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autoinjectors market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Autoinjectors Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the autoinjectors market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Autoinjectors Market Include

1. Autoinjectors Market Executive Summary

2. Autoinjectors Market Segments

3. Autoinjectors Market Size And Template Market Growth Rate

4. Key Autoinjectors Market Trends

5. Major Autoinjectors Market Drivers

……

25. Key Mergers And Acquisitions In The Autoinjectors Market

26. Top Autoinjectors Companies

27. Autoinjectors Market Opportunities And Strategies

28. Autoinjectors Market, Conclusions And Recommendations

29. Appendix

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The autoinjectors market has experienced exponential growth in recent years, witnessing a remarkable increase from $3.06 billion in 2023 to an estimated $3.79 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 23.6%. This surge is attributed to various factors such as the rising prevalence of chronic diseases, an aging population, the flourishing biotechnology and pharmaceutical sector, an increase in patient preference for self-administration, and supportive regulatory frameworks.

Unprecedented Growth Forecasted

• The autoinjectors market is poised for continuous exponential growth, projecting an impressive increase to $8.37 billion in 2028 at a CAGR of 21.9%.
• Factors fueling this growth include an expansion of therapeutic applications, rising healthcare costs, a heightened focus on patient-centered care, the advent of telemedicine and remote patient monitoring, and the burgeoning potential in emerging markets.

Chronic Diseases Propel Autoinjectors Market

Elevated Prevalence of Chronic Diseases

The autoinjectors market is set to benefit from the escalating prevalence of chronic diseases globally. These illnesses, lasting a year or longer, necessitate continuous medical attention. Chronic conditions like heart disease, cancer, rheumatoid arthritis, and diabetes are leading causes of mortality and disability worldwide. Auto injection devices play a crucial role in the management of chronic conditions, allowing patients to self-administer biologics and hormones regularly. According to Imperial College London research in 2020, chronic diseases are expected to cause nearly 41 million deaths globally each year, emphasizing the urgent need for effective self-administration tools.

Major Players Shaping the Market

Key players in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, and many others. These companies are pivotal in driving innovations and advancements in the field, contributing significantly to the market’s growth.

Read More On The Autoinjectors Market Report 2024 – https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

Innovations Driving Growth

Innovative and Sustainable Auto-Injector Solutions

Major companies are actively developing innovative and sustainable solutions to address the increasing demand for drug delivery devices. The Qfinity auto-injector platform, introduced by Jabil Inc. in May 2022, stands out as a notable example. This platform is designed to be sustainable and cost-effective, featuring durable materials capable of withstanding over 100 injections. Its pre-filled disposable cassette system reduces waste, making it a versatile, easy-to-use, accurate, and portable solution for drug self-administration.

Strategic Acquisitions for Drug Delivery Innovations

In April 2022, Halozyme Therapeutics Inc. acquired Antares Pharma Inc. for $960 million. This strategic move aims to expand Halozyme’s portfolio of drug delivery technologies and leverage Antares’ commercial infrastructure, positioning the combined entity as a leading innovator in drug delivery. Antares Pharma Inc., a key player in this acquisition, specializes in developing autoinjectors, further contributing to advancements in the field.

Market Segmentation

The autoinjectors market is segmented based on various criteria:

1. By Type:
   • Disposable Autoinjectors
   • Reusable Autoinjectors
2. By Therapy:
   • Rheumatoid Arthritis
   • Multiple Sclerosis
   • Diabetes
   • Anaphylaxis
   • Other Therapies
3. By Route of Administration:
   • Subcutaneous
   • Intramuscular
4. By Distribution Channel:
   • Online Retailer
   • Pharmacy
5. By End User:
   • Home Care Settings
   • Hospitals and Clinics
   • Other End-Users

Regional Dynamics

North America led the autoinjectors market in 2023, with Asia-Pacific anticipated as the fastest-growing region during the forecast period.

Conclusion

The autoinjectors market’s exponential growth signifies a paradigm shift in healthcare, placing greater emphasis on patient-centric solutions and self-administration. As chronic diseases continue to affect millions globally, the demand for efficient and innovative drug delivery devices like autoinjectors is set to surge. The industry’s focus on sustainability, coupled with advancements like connected and smart autoinjectors, needle-free options, and biologic drug delivery, promises a future where patients have more control over their treatments, ultimately reshaping the landscape of modern healthcare.

Request for A Sample Of The Global Autoinjectors Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=5249&type=smp